T2D Clinical Trials in Seoul
5 recruitingSeoul, South Korea
Showing 1–5 of 5 trials
Recruiting
Phase 1
Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers
Type 2 Diabetes Mellitus (T2DM)
Celltrion48 enrolled1 locationNCT07533539
Recruiting
Phase 4
Glycemic Variability of Combination Therapies in T2DM
Type 2 Diabetes Mellitus (T2DM)
JW Pharmaceutical178 enrolled1 locationNCT07442006
Recruiting
Phase 3
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Diabete Type 2T2DMDM
Celltrion171 enrolled1 locationNCT07093476
Recruiting
Phase 2
To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Type 2 Diabetes Mellitus (T2DM)
Hyundai Pharm160 enrolled1 locationNCT06647550
Recruiting
Not Applicable
To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
DyslipidemiasT2DM (Type 2 Diabetes Mellitus)
Korea University Anam Hospital3,958 enrolled1 locationNCT06293417